Artemisia annua belongs to the plant family of Asteraceae and is an annual short-day plant. Its stem is erect brownish or violet brown. The plant itself is hairless and naturally grows from 30 to 100 cm tall, although in cultivation it is possible for plants to reach a height of 200 cm.
Artemisinin is an ancient Chinese herbal therapy for malarial fevers which has been recently found to have potent activity against many forms of malarial organisms, including chloroquine-resistant Plasmodium falciparum. Artemisinin is a sesquiterpene lactone obtained from sweet wormwood, Artemisia annua, which is used as an ant malarial for the treatment of multi-drug resistant strains of falciparum malaria. It has a role as an antimalarial and a plant metabolite. It is a sesquiterpene lactone and an organic peroxide. Artemisinin has been used in trials studying the treatment of Schizophrenia, Malaria, Falciparum, and Plasmodium Falciparum. Artemisinin has been used in trials studying the treatment of Schizophrenia, Malaria, Falciparum, and Plasmodium Falciparum.
The Artemisinin Derivatives market was valued at USD 655 million in 2020 and expected to grow at a CAGR of 6.05% during the period from 2021 to 2027 to reach around USD 1,080 million in 2027. Artemisinin derivatives are a group of active pharmaceutical ingredients which are used in treatment against malaria. Artemisinin and its derivatives effectively fight against malarial and parasitic worm (helminth) infections. They have been proven to be most effective and potential drugs to kill the parasites and its life cycle. Artemisinin is typically derived from the plant Artemisia annua and sweet wormwood. Artemisia annua and sweet wormwood are long been used in traditional Chinese medicines.